Fundz

Briggs Morrison Appointed as New CEO of Arvinas, Inc.

PUBLIC · ARVNFeb 12, 2026

Position

Chief Executive Officer

Company

Arvinas

John Houston, Ph.D.
New HavenBiotechnologyHealth CareTherapeuticsresearch

Description

On February 10, 2026, John Houston, Ph.D., announced his resignation as president, CEO, and chairperson of Arvinas, Inc. Effective February 11, 2026, Briggs Morrison, M.D., has been appointed as the new CEO. Dr

Quick answer

Briggs Morrison Appointed as New CEO of Arvinas, Inc. (February 12, 2026). Arvinas is based in New Haven, Connecticut, United States.

What did Arvinas announce on February 12, 2026?
On February 10, 2026, John Houston, Ph.D., announced his resignation as president, CEO, and chairperson of Arvinas, Inc. Effective February 11, 2026, Briggs Morrison, M.D., has been appointed as the new CEO.
What does Arvinas do?
Arvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of...
Where is Arvinas based?
Arvinas is based in New Haven, Connecticut, United States.
Which similar companies made leadership changes around the same time?
Verrica (February 12, 2026), Cue Biopharma (February 12, 2026), Lahjavida Bio (February 13, 2026) and Actinium Pharmaceuticals (February 13, 2026) also announced leadership changes within 45 days of Arvinas.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and research

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Arvinas, and when

A new leader at Arvinas brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Arvinas raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Arvinas, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Arvinas. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Arvinas

Location

5 Science Park

New Haven, Connecticut, United States

About

Arvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC® Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC targeted protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. In addition to its robust preclinical pipeline of PROTAC protein degraders against validated and “undruggable” targets, the company has three investigational clinical-stage programs: ARV-766 and bavdegalutamide for the treatment of men with metastatic castration-resistant prostate cancer; and vepdegestrant (ARV-471) for the treatment of patients with locally advanced or metastatic ER+/HER2- breast cancer.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Arvinas changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Noah
Likely contact at this company
••••••••@••••••••

See Noah's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Arvinas's next move

Learn about Strategic plan

Arvinas changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.